[Autotransplantation in lymphomas: is it effective?].

Area of Science:

• Hematology
• Oncology
• Clinical Trials

Background:

• Advanced intermediate and high-grade non-Hodgkin lymphoma (NHL) require effective treatment strategies.
• Intensive chemotherapy with or without radiation followed by autologous stem cell transplantation (ASCT) is a potential option.

Purpose of the Study:

• To compare the outcomes of ASCT with conventional chemotherapy in patients with advanced intermediate and high-grade NHL.
• To evaluate the effectiveness of ASCT in achieving complete remission and disease-free survival.

Main Methods:

• A meta-analysis of 12 studies involving ASCT for NHL.
• Comparison of ASCT outcomes with data from 29 chemotherapy-only studies.
• Analysis of complete remission rates and two-year disease-free survival.

Main Results:

• ASCT achieved a 53% complete remission rate versus 17% for chemotherapy.
• Two-year disease-free survival was 16% for ASCT compared to 3% for chemotherapy.
• Potential biases in subject selection or time-to-treatment for ASCT cohorts were noted.

Conclusions:

• ASCT demonstrates superior short-term outcomes in complete remission and disease-free survival for advanced NHL.
• Randomized controlled trials are essential to definitively establish ASCT superiority over chemotherapy.
• The potential benefit of higher-dose chemotherapy without ASCT warrants further investigation.